Suzhou Fushilai Financials
| 301258 Stock | 27.94 0.05 0.18% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 119.7 M | 96.2 M |
|
|
Suzhou | Select Account or Indicator |
Understanding current and past Suzhou Fushilai Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Suzhou Fushilai's financial statements are interrelated, with each one affecting the others. For example, an increase in Suzhou Fushilai's assets may result in an increase in income on the income statement.
Please note, the presentation of Suzhou Fushilai's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Suzhou Fushilai's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Suzhou Fushilai's management manipulating its earnings.
Suzhou Fushilai Stock Summary
Suzhou Fushilai competes with Xinya Electronic, Unigroup Guoxin, Pengxin International, Success Electronics, and Shenzhen Clou. Suzhou Fushilai is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE1000058W2 |
| Business Address | No16 Haiwang Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.fuslai.com |
| Phone | 86 51 2528 35990 |
You should never invest in Suzhou Fushilai without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Suzhou Stock, because this is throwing your money away. Analyzing the key information contained in Suzhou Fushilai's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Suzhou Fushilai Key Financial Ratios
Suzhou Fushilai's financial ratios allow both analysts and investors to convert raw data from Suzhou Fushilai's financial statements into concise, actionable information that can be used to evaluate the performance of Suzhou Fushilai over time and compare it to other companies across industries.| Revenue | 489.29 M | ||||
| Gross Profit | 253.31 M | ||||
| EBITDA | 49 M | ||||
| Net Income | 112.18 M | ||||
| Total Asset | 2.12 B |
Suzhou Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Suzhou Fushilai's current stock value. Our valuation model uses many indicators to compare Suzhou Fushilai value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Suzhou Fushilai competition to find correlations between indicators driving Suzhou Fushilai's intrinsic value. More Info.Suzhou Fushilai Pharmaceutical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Suzhou Fushilai by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Suzhou Fushilai's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Suzhou Fushilai Phar Systematic Risk
Suzhou Fushilai's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Suzhou Fushilai volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Suzhou Fushilai Phar correlated with the market. If Beta is less than 0 Suzhou Fushilai generally moves in the opposite direction as compared to the market. If Suzhou Fushilai Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Suzhou Fushilai Phar is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Suzhou Fushilai is generally in the same direction as the market. If Beta > 1 Suzhou Fushilai moves generally in the same direction as, but more than the movement of the benchmark.
Suzhou Fushilai Pharmaceutical Total Assets Over Time
Suzhou Fushilai December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Suzhou Fushilai help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Suzhou Fushilai Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Suzhou Fushilai Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Suzhou Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Suzhou Fushilai's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.52 | |||
| Information Ratio | 0.0968 | |||
| Maximum Drawdown | 27.27 | |||
| Value At Risk | (4.87) | |||
| Potential Upside | 6.9 |
Complementary Tools for Suzhou Stock analysis
When running Suzhou Fushilai's price analysis, check to measure Suzhou Fushilai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Suzhou Fushilai is operating at the current time. Most of Suzhou Fushilai's value examination focuses on studying past and present price action to predict the probability of Suzhou Fushilai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Suzhou Fushilai's price. Additionally, you may evaluate how the addition of Suzhou Fushilai to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |